🚫FDA Debarment Order
Justin Cole Henry: Final Debarment Order
Summary
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Justin Cole Henry for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Henry was convicted of a felony under Federal law for possession with intent to distribute a Schedule III controlled substance. The factual basis supporting Mr. Henry's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Henry was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of February 24, 2025 (30 days after receipt of the notice), Mr. Henry had not responded. Mr. Henry's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$$ - High
The debarment order against Justin Cole Henry directly impacts businesses involved in drug importation, as it establishes a precedent for regulatory compliance and risk management. Non-compliance can lead to significant legal and financial repercussions. Additionally, the FDA's actions could influence market competition and operational strategies among businesses in the pharmaceuticals and health industries.